BackOpiant Pharmaceuticals Overview

Opiant Pharmaceuticals Total Revenue

Revenue analysis for OPNT.

Quarterly Revenue

$173.87M
↑ 1138.33% YoY

As of Sep 2022

Annual Revenue (TTM)

$191.43M
↑ 431.25% YoY

Trailing 12 months ending Sep 2022

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin